Hint mode is switched on Switch off
For swift navigation between sections

Organization: Novartis Capital
LEI 5493002KF87V5RSRQS84

Organization name
Novartis Capital Corporation
Country name
Switzerland
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
1,000 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Novartis Capital Corporation is a finance subsidiary indirectly owned 100% by Novartis AG and was incorporated as a corporation under the laws of Delaware on July 23, 2008. It exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of Novartis AG.

Awards

News

19/02/2024 Moody's Investors Service upgrades LT- local currency credit rating of Novartis Capital to "Aa3" from "A1"; outlook stable
13/02/2023 Moody's Investors Service revised outlook on Novartis Capital to positive and affirmed at "A1" (LT- local currency) credit rating
08/11/2021 Moody's Investors Service affirms Novartis Capital at "A1" (LT- local currency credit rating); outlook stable
27/11/2019 Moody's Investors Service affirms Novartis Capital at "A1" (LT- local currency credit rating); outlook stable
03/07/2018 Moody's Investors Service downgrades LT- local currency credit rating of Novartis Capital to "A1"; outlook stable
All organization news

Documentation

Affiliates

Stocks

Latest issues

Show all

Bond classification

  • Organization does not disclose IFRS/US GAAP financial statements

Bond debt by currency

Show more Hide

Codes

  • LEI
    5493002KF87V5RSRQS84
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001443411

Credit and ESG Ratings

Macroeconomic Indicators - Novartis Capital

Registration is required to get access.